Fractyl Laboratories

View the org chart displaying its 16 main executives

Most searched biographies at Fractyl Laboratories

• Harith Rajagopalan, Chief Executive Officer and Director
• Allan Will, Chairman of the Board
• Kelly Barnes, Director

Popular executive movements at Fractyl Laboratories

• Timothy Kieffer has joined the company as Chief Scientific Officer  (posted on September 17 2023).

Create your alert
to follow the executive moves at Fractyl Laboratories.

Fractyl Laboratories has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Fractyl Laboratories

• Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | Fractyl Health, Inc.
• Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs | Fractyl Health, Inc.
• Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes | Fractyl Health, Inc.
• Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity | Fractyl
• Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials | Fractyl Health, Inc.
• Fractyl Health Announces Nomination of RJVA-001 as First Clinical Candidate in it's Rejuva® GLP-1 Gene Therapy Platform | Fractyl Health, Inc.
• Events & Presentations | Fractyl Health, Inc.
• Fractyl Health Announces Pricing of Initial Public Offering | Fractyl Health, Inc.
• In the News | Fractyl Health, Inc.
• News Releases | Fractyl Health, Inc.
• View more press releases Close

Social media about Fractyl Laboratories

• Fractyl Laboratories on Wikipedia, Google News & Yahoo Finance
• Fractyl Laboratories on LinkedIn, Twitter & YouTube

Contact by email its executives including Harith Rajagopalan

Call Fractyl Laboratories at +1 781...

View the org chart

Register to receive your alert

Report an error